Carson Wealth (CWM LLC)’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-243
Closed 5752
2025
Q4
$0 Sell
243
-749
-76% -$1.18K ﹤0.01% 5526
2025
Q3
$2K Sell
992
-4,456
-82% -$7.21K ﹤0.01% 5021
2025
Q2
$7K Sell
5,448
-2,960
-35% -$4.29K ﹤0.01% 4468
2025
Q1
$11K Sell
8,408
-874
-9% -$2.28K ﹤0.01% 4060
2024
Q4
$30K Sell
9,282
-870
-9% -$3.13K ﹤0.01% 3177
2024
Q3
$33K Buy
10,152
+9,973
+5,572% +$38.9K ﹤0.01% 3027
2024
Q2
$1K Buy
179
+122
+214% +$1.19K ﹤0.01% 4419
2024
Q1
$1K Buy
57
+30
+111% +$453 ﹤0.01% 4164
2023
Q4
$0 Sell
27
-90
-77% -$622 ﹤0.01% 4373
2023
Q3
$1K Buy
117
+27
+30% +$134 ﹤0.01% 4017
2023
Q2
$0 Buy
+90
New +$555 ﹤0.01% 4352
2022
Q3
Sell
-49
Closed 4085
2022
Q2
$0 Buy
+49
New +$258 ﹤0.01% 3984

Other funds holding MGNX

Carson Wealth (CWM LLC)'s MGNX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) sold out of MacroGenics (MGNX) in Q1 2026, closing a stake of 243 shares.

Carson Wealth (CWM LLC) first reported a position in MGNX in Q2 2022 and held it in 12 quarters. The position peaked at $33K in Q3 2024. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Carson Wealth (CWM LLC) reported no remaining MacroGenics position as of Q1 2026 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 243 MacroGenics shares in Q1 2026.
  • Carson Wealth (CWM LLC) first reported a position in MacroGenics in Q2 2022 and held it in 12 quarters.
  • Carson Wealth (CWM LLC)'s MacroGenics position peaked at $33K in Q3 2024.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.